Views & Analysis | Perspectives on pharma industry issues

Digital

Patient access will not improve without better digital found...

Digital health cannot succeed without infrastructure that supports it at every level.

Digital

The SPR must be built for the health system to come

The creation of a Single Patient Record (SPR) is one of the most significant reforms to health data in a generation.

Digital

Axtria's Asheesh Sharma speaks with Anvita Karara and Bharti Rai at Axtria Ignite last month.

Axtria Ignite 2026: Intangible factors to enable AI success

At Axtria Ignite, experts explored how culture, training, and strategy create competitive advantage in an increasingly commodified AI world.

R&D

European launch: Manufacturing as cornerstone for success

In Europe, manufacturing may not make headlines in pharma partnering, but it’s one of the foundations on which strong partnerships must be built.

Patients

Why Britain's blood tests are only as reliable as the journe...

What happens in phlebotomy has a huge impact in pathology, and the different funding streams and management means that interests are no longer aligned

Digital

12 shots at staying ahead of AI in the workplace

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional, and global life sciences communications to offer some little tips for enjoying a b

R&D

Professor Giles Yeo on the genetic science of body weight

In the run up to The World Without Disease summit on 21st June, Prof Giles Yeo gives us as a taste of his keynote presentation and how genetics can impact the science of body weight

Market Access

This is what’s keeping pharmaceutical CISOs up at night

The role of CISO in the pharmaceutical industry is a position that comes with a great deal of responsibility, but designing and implementing a strategy that checks all the boxes is a tall ask

Sales & Marketing

Why trust is becoming pharma’s most important visibility met...

Any gap between an AI-generated answer and a product’s approved profile carries consequences for prescribing decisions and patient safety.

Sales & Marketing

Pharma is marketing to the wrong mind

On the benefits of instinctive marketing, over either rational or emotional.

Digital

Patient access will not improve without better digital found...

Digital health cannot succeed without infrastructure that supports it at every level.

Digital

The SPR must be built for the health system to come

The creation of a Single Patient Record (SPR) is one of the most significant reforms to health data in a generation.

Market Access

Preparing for the pharma fraud enforcement surge

Here is what robust, risk-based compliance looks like in 2026.

Market Access

Changing Faces: Boards of Directors and Advisory Boards, May...

The latest Board moves reflect a focus on experience in commercialisation, corporate governance, and therapeutic development.

Oncology

Establishing ctDNA as a validated primary surrogate endpoint

Circulating tumour DNA (ctDNA) has emerged as a promising primary surrogate endpoint in solid tumour oncology.

Oncology

radiotherapy session for young man with cancer

Early diagnosis means little without timely treatment

Early diagnosis only changes outcomes if it is followed by timely treatment.

Oncology

ASCO 2026: Astellas innovates in ADCs and T Cell engagers, w...

Patients

Why Britain's blood tests are only as reliable as the journe...

What happens in phlebotomy has a huge impact in pathology, and the different funding streams and management means that interests are no longer aligned

Patients